Methods and compositions to modulate hair growth

1. A method for inducing hair growth in a subject comprising administering a population of stem cell-derived dermal papillae-like cells to the subject, wherein the population of stem cell-derived dermal papillae-like cells were obtained via:

culturing adherent cells from a population of stem cell-derived neural crest cells, wherein the population of stem cell-derived neural crest cells lack a marker selected from the group consisting of versican, smooth muscle actin, and alkaline phosphatase, and

differentiating the adherent cells into the population of stem-cell derived dermal papillae-like cells in a serum-containing media,

thereby inducing hair growth in the subject.

2. The method of claim 1 , wherein the stem cell-derived dermal papillae-like cells are human stem cell-derived dermal papillae-like cells.

3. The method of claim 1 , wherein the population of stem cell-derived neural crest cells were obtained via differentiation of a population of stem cells into a population of stem cell-derived neural crest cells, wherein the population of stem cell-derived neural crest cells lack a marker selected from the group consisting of versican, smooth muscle actin, and alkaline phosphatase.

4. The method of claim 3 , wherein the population of stem cells is a population of human stem cells.

5. The method of claim 4 , wherein the population of human stem cells comprises human embryonic stem cells or human induced pluripotent stem cells.

6. The method of claim 5 , wherein the human induced pluripotent stem cells were generated from fibroblasts, renal epithelial cells, or blood cells.

7. The method of claim 5 , wherein the human induced pluripotent stem cells were generated from human BJ fibroblasts.

8. The method of claim 3 , wherein the population of stem cells was cultured under conditions to form clusters.

9. The method of claim 1 , wherein the population of stem cell-derived neural crest cells was analyzed to confirm the presence of at least one marker selected from Sox 10, Foxd3, integrin alpha 4, cognate receptor for fibronectin, CD47, CD 184, CD44, P-75, and nestin.

10. The method of claim 1 , wherein the population of stem cell-derived neural crest cells was analyzed to confirm the presence of at least one marker selected from P-75, nestin, versican, smooth muscle actin, alkaline phosphatase, and vimentin.

11. The method of claim 3 , wherein the population of stem cells was obtained from the subject.

12. The method of claim 3 , wherein the population of stem cells was not obtained from the subject.

13. The method of claim 1 , wherein administering a population of stem cell-derived dermal papillae-like cells to the subject comprises subcutaneous transplantation.

14. The method of claim 1 , wherein the population of stem cell-derived dermal papillae-like cells is administered to a location comprising hair on a skin of the subject.

15. The method of claim 14 , wherein the location is scalp, face, upper lip, chin, eyebrow, eyelash, arm, leg, back, torso, or abdomen.

16. The method of claim 14 , wherein the location comprises scar tissue.

17. The method of claim 1 , wherein the subject has alopecia.

18. The method of claim 1 , wherein the subject is a mammal.

19. The method of claim 1 , wherein the subject is a human.